Translating Immuno-Oncology into Health Actions
Cancer immunotherapy focused public-private collaborative for better research, innovation, health care and public awareness
Cancer IO is a cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland’s Personalized Health Program.
Cancer IO is a University of Helsinki coordinated project that integrates immuno-oncology (IO) activities at the Universities of Helsinki and Turku, 4 University hospitals and one central hospital, 11 Finnish small or medium enterprises, 3 cancer patient organizations and the 10 largest IO-investing pharmaceutical companies.
News & updates
Welcome to watch a recording of our second Sebinar! This time we hear about the latest developments in the “next-gen” immunotherapies (post-immune checkpoint blockade) in the form of new therapies targeting the innate immune system.
This video is a part of Cancer IO Sebinar Series session “Ex vivo models in IO research”, in which Research Coordinator Jeroen Pouwels from Cancer IO project gives us an introduction to preclinical cancer models. https://youtu.be/FCx4unktbow
World Cancer Day every 4 February is the global uniting initiative led by the Union for International Cancer Control (UICC). Aim of the World Cancer Day is to raise worldwide awareness, improve education and catalyst personal, collective and government action to reduce cancer deaths and improve access to life-saving cancer treatment – no matter who you are or where you live.